Evosep

Evosep

Odense, Denmark· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $21.5M

Overview

Evosep is a proteomics technology company developing hardware and consumables to standardize and automate workflows for liquid chromatography-mass spectrometry (LC-MS). Its core platform, centered on the Evosep Eno chromatography system and Evotip Pure disposable trap columns, is designed to dramatically increase throughput and reproducibility in protein analysis for research and clinical diagnostics. By simplifying complex proteomics processes, Evosep targets the growing need for scalable, robust tools to validate biomarkers and advance personalized medicine, positioning itself as a key enabler in the transition of proteomics from research to the clinic.

ProteomicsDiagnostics

Technology Platform

Integrated liquid chromatography and consumable platform (Evosep Eno system and Evotip Pure) for standardized, high-throughput sample preparation and separation in mass spectrometry-based proteomics.

Funding History

2
Total raised:$21.5M
Series A$20M
Seed$1.5M

Opportunities

The massive growth in proteomics for biomarker discovery and precision medicine creates demand for robust, high-throughput tools.
Evosep's platform is uniquely positioned to enable the transition of complex LC-MS workflows from research labs into clinical diagnostics and biopharma quality control, representing a large, untapped market.

Risk Factors

Evosep faces competition from large, established chromatography and mass spectrometry corporations with greater resources.
The company's growth is also tied to the pace of clinical adoption of proteomics, which faces regulatory and reimbursement hurdles.
Executing global scaling while maintaining product quality and technological innovation presents an ongoing challenge.

Competitive Landscape

Evosep competes in the proteomics workflow sector against major life science tools companies like Thermo Fisher Scientific, Waters, and Agilent, which offer traditional HPLC/UPLC systems. Its differentiation lies in its specialized focus on standardized, high-throughput proteomics workflows using disposable tips. It also competes with other niche players and startups developing microfluidic and automated sample preparation solutions for MS.